Mohamad Mohty
Steven Pavletic
Daniel WolffSymposium | Early treatment strategies for SR-GvHD
Daniel Wolff, University Hospital Regensburg, DE, presented the first session at the recent GvHD Hub virtual symposium, titled, Early treatment strategies for SR-GvHD.
All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
TRANSLATE
The gvhd Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the gvhd Hub cannot guarantee the accuracy of translated content. The gvhd and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The GvHD Hub is an independent medical education platform, sponsored by Medac and supported through grants from Sanofi and Therakos. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View GvHD content recommended for you
Symposium Series | Guidance vs practice: How can we improve treatment of SR-GvHD?
The GvHD Hub held a virtual symposium on October 21, 2025, titled Guidance vs practice: How can we improve treatment of SR-GvHD? The symposium was chaired by Mohamad Mohty, with presentations from Daniel Wolff and Steven Pavletic, and included Q&A sessions with live audience participation. Explore each session below:
Symposium | Guidance vs practice: How can we improve treatment of SR-GvHD?
.webp)
.webp)
Symposium | The importance of real-world data in allogeneic stem cell transplantation: A focus on cGvHD
Mohamad Mohty, Sorbonne University Hôpital Saint-Antoine, Paris, FR, presented the second session at the recent GvHD Hub virtual symposium, titled The importance of real-world data in allogeneic cell transplantation: A focus on cGvHD.
Symposium | Quality of life and symptoms in cGvHD
Steven Pavletic, Bethesda, US, presented the final session – titled, Quality of life and symptoms in cGvHD – at the recent GvHD Hub virtual symposium.
This educational resource is independently supported by Sanofi. All content was developed by SES in collaboration with an expert steering committee. Funders were allowed no influence on the content of this resource.
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content